FJ
Francisco Jose Dopazo Gonzalez
About Francisco Jose Dopazo Gonzalez
Data last updated:
Francisco Jose Dopazo Gonzalez is a Director at Hemogenomics Private Limited (since 2025). The company operates in Healthcare. Hemogenomics Private Limited reported revenue of ₹103 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Hemogenomics Private Limited U73100KA2002PTC030032 | Director | 10 Jan 2025 | 2002 | ₹103 Cr (FY 2025) | Active |
Board colleagues of Francisco Jose Dopazo Gonzalez
| Name | DIN | Company | Designation |
|---|---|---|---|
| Anurag Bagaria | 00111917 | Hemogenomics Private Limited | Director |
| Sumit Bagaria | 00030584 | Hemogenomics Private Limited | Managing Director |
| William J Rutter | 02443521 | Hemogenomics Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Francisco Jose Dopazo Gonzalez
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Francisco Jose Dopazo Gonzalez
Francisco Jose Dopazo Gonzalez currently holds 1 directorship: Hemogenomics Private Limited (Director, since 10 Jan 2025, revenue ₹103 Cr (FY 2025)).
Francisco Jose Dopazo Gonzalez was first appointed on 10 Jan 2025 as Director at Hemogenomics Private Limited.
The current boards of Francisco Jose Dopazo Gonzalez's companies include Anurag Bagaria (Hemogenomics Private Limited), Sumit Bagaria (Hemogenomics Private Limited), William J Rutter (Hemogenomics Private Limited).